Animal models and treatments for addiction and depression co-morbidity Neil E. PatersonAthina Markou OriginalPaper Pages: 1 - 32
Pharmacotherapy for schizophrenia and co-occurring substance use disorders Alan I. Green OriginalPaper Pages: 33 - 39
Modeling tardive dyskinesia: Predictive 5-HT2C receptor antagonist treatment Richard M. KostrzewaNuo-Yu HuangRyszard Brus OriginalPaper Pages: 41 - 50
Association in alcoholic patients between Psychopathic Traits and the additive effect of allelic forms of theCNR1 andFAAH endocannabinoid genes, and the 3′ Region of theDRD2 Gene Janet HoenickaGuillermo PonceTomás Palomo OriginalPaper Pages: 51 - 59
From dopaminergic genes to psychiatric disorders Janet HoenickaMaría aragüésTomás Palomo OriginalPaper Pages: 61 - 71
Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? evidence fromDISC1, GRIK4 andNRG1 Douglas H. R. BlackwoodBen J. PickardWalter J. Muir OriginalPaper Pages: 73 - 83